- Oops!Something went wrong.Please try again later.
Bausch + Lomb Corp. reported Wednesday first-quarter profit that topped expectations but revenue that came up short, as growth in vision care and surgical segment revenue was partially offset by declines in ophthalmic pharmaceuticals revenue. The contact lens and surgical device maker's stock was still inactive in premarket trading. Net income fell to $20 million, or 6 cents a share, from $27 million, or 8 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per